Document is current
Any future updates will be listed below
-
Authors
Sørland, Kaia Ingerdatter https://orcid.org/0000-0001-9335-9968
Sunoqrot, Mohammed R. S.
Sandsmark, Elise
Langørgen, Sverre
Bertilsson, Helena
Trimble, Christopher G.
Lin, Gigin
Selnæs, Kirsten M.
Goa, Pål E.
Bathen, Tone F.
Elschot, Mattijs
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST 109-2628-B-182A-007)
National Health Research Institutes (NHRI-109BCCO-MF-202009-02)
Chang Gung Medical Foundation (CLRPG3K0022, CPRPG3G0023)
The Research Council of Norway (295013)
The Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (90265300)
Norges Teknisk-Naturvitenskapelige Universitet
The Liaison Committee for Education, Research and Innovation in Central Norway (905481)
NTNU Norwegian University of Science and Technology
- License Information
-
More Information
Article History
Received: 24 September 2021
Revised: 22 December 2021
Accepted: 23 January 2022
First Online: 12 February 2022
Declarations
:
: The authors have no competing interests to declare that are relevant to the content of this article.
: All procedures performed at St. Olavs hospital in studies involving human participants were in accordance with the ethical standards of the Regional Committee for Medical and Health Research Ethics (REC) in Central Norway (REC identifiers 2013/1869, 2014/1289, 2017/576), and all asymptomatic volunteers and prostate cancer patients signed informed consents prior to the initiation of the study. The institutional review board at Chang Gung Memorial Hospital approved the protocol of this study (Chang Gung Medical Foundation IRB 201901295B0), where informed consent was waived because of the retrospective nature of the study and the analysis used anonymous clinical data.
